VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
USPH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
USPHU.S. Physical Therapy, Inc.
$68.78$1.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksUSPHQuarterly Financials

U.S. Physical Therapy, Inc. (USPH) Quarterly Financials

120+ quarters historyFree accessUpdated daily

U.S. Physical Therapy, Inc. (USPH) quarterly income statement — complete revenue, gross profit & net income history

USPH Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue164.33M202.73M164.02M164.18M152.55M180.45M168.03M167.19M155.68M154.8M150.01M151.49M
Revenue Growth %7.72%12.35%-2.39%-1.8%-2.01%16.57%12.02%10.37%4.83%9.65%7.45%7.7%
Cost of Goods Sold131.58M160.86M127.15M122.56M121.48M146.75M138.9M133.33M127.27M124.28M122.08M119.28M
COGS % of Revenue80.07%79.35%77.52%74.65%79.64%81.33%82.66%79.75%81.76%80.29%81.38%78.74%
Gross Profit32.75M41.86M36.87M41.62M31.07M33.7M29.13M33.86M28.4M30.52M27.93M32.21M
Gross Margin %19.93%20.65%22.48%25.35%20.36%18.67%17.34%20.25%18.24%19.71%18.62%21.26%
Gross Profit Growth %5.43%24.24%26.57%22.92%9.38%10.42%4.3%5.14%-7.96%9.65%4.27%4.5%
Operating Expenses20.27M19.86M11.54M16.69M11.42M19.16M14.38M18.3M13.47M31.4M12.05M12.14M
OpEx % of Revenue12.34%9.79%7.04%10.16%7.49%10.62%8.56%10.94%8.65%20.28%8.03%8.02%
Selling, General & Admin00017.48M16.25M15.57M14.38M000012.14M
SG&A % of Revenue---10.64%10.65%8.63%8.56%----8.02%
Research & Development000000000000
R&D % of Revenue------------
Other Operating Expenses1000K1000K1000K-790K-1000K1000K01000K1000K1000K1000K0
Operating Income14.48M22.01M25.33M24.94M19.64M14.54M14.75M15.57M14.93M-880K15.88M20.06M
Operating Margin %8.81%10.86%15.44%15.19%12.88%8.06%8.78%9.31%9.59%-0.57%10.59%13.24%
Operating Income Growth %-26.29%51.38%71.78%60.2%31.58%1752.05%-7.15%-22.41%-12.18%-112.95%6.62%-0.09%
EBITDA20.48M26.64M31.16M31M25.51M20.22M19.13M20.08M19.02M3.23M19.85M23.89M
EBITDA Margin %12.46%13.14%19%18.88%16.72%11.21%11.39%12.01%12.22%2.09%13.23%15.77%
EBITDA Growth %-19.72%31.74%62.87%54.35%34.1%525.52%-3.6%-15.94%-8.48%-69.46%7.01%1.42%
D&A (Non-Cash Add-back)6M4.63M5.83M6.06M5.87M5.68M4.39M4.51M4.09M4.11M3.97M3.83M
EBIT14.48M17.31M25.28M25.07M19.61M20.37M14.35M16.77M16.72M2.12M17.88M21.73M
Net Interest Income-2.77M-2.33M-2.38M-2.39M-2.25M-1.74M-1M-906K-425K-427K-428K-2.12M
Interest Income16K20K33K28K24K306K1.02M1.07M1.54M1.58M1.67M517K
Interest Expense2.79M2.35M2.41M2.42M2.28M2.05M2.02M1.98M1.97M2.01M2.1M2.63M
Other Income/Expense-3.92M-7.05M-2.46M-2.29M-2.31M3.78M-2.41M-772K-172K986K-102K-967K
Pretax Income10.56M14.96M22.88M22.65M17.33M18.32M12.34M14.79M14.76M106K15.78M19.09M
Pretax Margin %6.43%7.38%13.95%13.8%11.36%10.15%7.34%8.85%9.48%0.07%10.52%12.61%
Income Tax2.41M5.78M5.23M4.93M3.86M5.83M2.56M3.08M3.14M1.4M3.56M4.23M
Effective Tax Rate %22.79%38.66%22.88%21.78%22.28%31.81%20.74%20.84%21.27%1319.81%22.54%22.16%
Net Income5.04M-10.55M7.24M8.81M9.9M7.44M5.53M6.88M6.61M-7.92M7.01M8.05M
Net Margin %3.07%-5.2%4.42%5.37%6.49%4.12%3.29%4.12%4.24%-5.12%4.67%5.32%
Net Income Growth %-49.11%-241.8%30.95%28.05%49.83%193.9%-21.12%-14.53%-12.25%-626.7%-25.09%-29.05%
Net Income (Continuing)8.16M9.18M17.64M17.72M13.47M12.49M9.78M11.71M11.62M-1.29M12.22M14.86M
Discontinued Operations000000000000
Minority Interest313.9M293.31M278.88M264.84M261.75M270.12M187.96M185.4M192.19M176.04M176.23M167.01M
EPS (Diluted)-0.12-0.440.480.580.800.520.390.470.46-0.380.510.64
EPS Growth %-115%-184.62%23.08%23.4%73.91%236.84%-23.53%-26.56%-47.73%-290%-29.17%-26.44%
EPS (Basic)-0.12-0.440.480.580.800.520.390.470.46-0.380.510.64
Diluted Shares Outstanding15.17M15.18M15.2M15.2M15.13M15.06M15.08M15.07M15.02M14.99M14.99M13.72M
Basic Shares Outstanding15.17M15.18M15.2M15.2M15.13M15.06M15.08M15.07M15.02M14.99M14.99M13.72M
Dividend Payout Ratio--94.46%155.17%69.06%89.3%119.94%192.68%--91.91%139.53%